ASP Isotopes (NASDAQ:ASPI) CEO Paul Elliot Mann Sells 83,759 Shares of Stock

ASP Isotopes Inc. (NASDAQ:ASPI) CEO Paul Elliot Mann sold 83,759 shares of the stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $7.76, for a total transaction of $649,969.84. Following the sale, the chief executive officer directly owned 9,579,845 shares in the company, valued at $74,339,597.20. This trade represents a 0.87% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Paul Elliot Mann also recently made the following trade(s):

• On Tuesday, June 2nd, Paul Elliot Mann sold 83,758 shares of ASP Isotopes stock. The shares were sold at an average price of $8.29, for a total transaction of $694,353.82.

ASP Isotopes Stock Performance

Shares of ASPI stock opened at $7.55 on Thursday. ASP Isotopes Inc. has a one year low of $3.92 and a one year high of $14.49. The company’s 50-day moving average is $5.44 and its 200 day moving average is $5.87. The company has a market capitalization of $950.55 million, a price-to-earnings ratio of -3.63 and a beta of 3.42. The company has a debt-to-equity ratio of 0.69, a quick ratio of 4.37 and a current ratio of 4.39.

ASP Isotopes (NASDAQ:ASPI) last announced its quarterly earnings results on Wednesday, May 20th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.28) by $0.06. The firm had revenue of $8.36 million for the quarter, compared to the consensus estimate of $3.68 million. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%.

Hedge Funds Weigh In On ASP Isotopes

Several institutional investors have recently made changes to their positions in the business. Encompass Capital Advisors LLC bought a new position in shares of ASP Isotopes in the 1st quarter worth approximately $30,551,000. Alyeska Investment Group L.P. lifted its stake in shares of ASP Isotopes by 73.4% in the 4th quarter. Alyeska Investment Group L.P. now owns 4,895,546 shares of the company’s stock worth $26,191,000 after purchasing an additional 2,072,851 shares during the period. Vanguard Group Inc. lifted its stake in shares of ASP Isotopes by 37.9% in the 3rd quarter. Vanguard Group Inc. now owns 4,516,763 shares of the company’s stock worth $43,451,000 after purchasing an additional 1,241,024 shares during the period. Rovida Investment Management Ltd lifted its stake in shares of ASP Isotopes by 28.1% in the 4th quarter. Rovida Investment Management Ltd now owns 4,100,000 shares of the company’s stock worth $21,894,000 after purchasing an additional 900,000 shares during the period. Finally, UBS Group AG lifted its stake in shares of ASP Isotopes by 150.3% in the 4th quarter. UBS Group AG now owns 2,406,457 shares of the company’s stock worth $12,875,000 after purchasing an additional 1,445,165 shares during the period. Institutional investors own 16.80% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a report on Friday, March 27th. Canaccord Genuity Group reaffirmed a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a report on Tuesday, April 14th. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $13.00.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.